Close
30 Year Old Woman Has Severe Visual Loss after MMR

Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman.

Abstract

Purpose. To report a case of unilateral optic neuritis following Measles-Mumps-Rubella (MMR) vaccination. Methods. A 30-year-old female developed unilateral optic neuritis five days after a Measles-Mumps-Rubella (MMR) booster vaccination. The patient displayed unilateral involvement, with severe visual loss. However, visual acuity improved significantly after four days of intravenous steroid therapy with 500 mg/day of methylprednisolone. Conclusions. Optic neuritis is one of the rare complications associated with the mumps, measles, and rubella vaccine. It may be a toxic reaction to the nonviral component of the vaccine, but the exact etiology is unknown. Postvaccination neuritis is generally bilateral and usually affects children. In adults, unilateral optic neuritis is usually correlated with multiple sclerosis (MS).

Source: Case Rep Ophthalmol Med. 2016;2016:8740264. doi: 10.1155/2016/8740264. Epub 2016 Apr 19.

http://www.ncbi.nlm.nih.gov/pubmed/27195163

Sudden hearing loss after rabies vaccination.

Abstract

BACKGROUND:

Sudden hearing loss developing after immunisation is a very rare situation. Rabies is a viral disease characterised by encephalitis and death. Treatment involves active and passive immunisation. Neurologic complications including Guillain-Barre syndrome or facial paralysis are reported in the literature as a side effect after rabies immunisation.

CASE REPORT:

Sudden hearing loss was detected in an 11 year-old male patient who had taken the medication for rabies immunisation.

CONCLUSION:

This study presents a case report of sudden hearing loss developing after rabies immunisation – no other aetiological factors were detected and clinical management is discussed in light of the literature.

Source: Balkan Med J. 2013 Sep;30(3):327-8. doi: 10.5152/balkanmedj.2013.8465. Epub 2013 Sep 1.

https://www.ncbi.nlm.nih.gov/pubmed/25207131

Add your comment or reply. Your email address will not be published. Required fields are marked *